Feature Channels: Vaccines

Filters close
10-Jun-2013 5:00 PM EDT
Experimental Vaccine Shows Promise Against TB Meningitis
Johns Hopkins Medicine

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

Released: 11-Jun-2013 3:00 PM EDT
Workers Do Not Quit Due To Mandatory Flu Shot
Loyola Medicine

In its fourth year with 99 percent compliance, Loyola University Health System's mandatory flu shot program is the subject of a study presented by Jorge Parada, MD, Loyola University Health System, presented at an infectious disease conference.

Released: 7-Jun-2013 12:00 PM EDT
Vaccinating Children Against HPV?
Dana-Farber Cancer Institute

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at Dana-Farber's head and neck oncology program offers comment.

5-Jun-2013 9:00 AM EDT
Gut Bacteria Play Key Role in Vaccination
University of Maryland Medical Center

The bacteria that live in the human gut may play an important role in immune response to vaccines and infection by wild-type enteric organisms, according to two recent studies from researchers at the University of Maryland School of Medicine

28-May-2013 12:55 PM EDT
Gene Therapy Gives Mice Broad Protection to Pandemic Flu Strains, Including 1918 Flu
Perelman School of Medicine at the University of Pennsylvania

Researchers have developed a new gene therapy to thwart a potential influenza pandemic. They demonstrated that a single dose of an adeno-associated virus expressing a broadly neutralizing flu antibody into the noses of animal models gives them complete protection and substantial reductions in flu replication when exposed to lethal strains of H5N1 and H1N1 flu virus. These were isolated from samples associated from historic human pandemics – the infamous 1918 flu pandemic and another from 2009.

Released: 21-May-2013 12:40 PM EDT
Poliovirus Vaccine Trial Shows Early Promise for Recurrent Glioblastoma
Duke Health

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

16-May-2013 10:00 AM EDT
Leading Explanations for Whooping Cough's Resurgence Don't Stand Up to Scrutiny
University of Michigan

Whooping cough has exploded in the United States and some other developed countries in recent decades, and many experts suspect ineffective childhood vaccines for the alarming resurgence.

9-May-2013 3:00 PM EDT
Lyme Disease Vaccine Shows Promise in Clinical Trial
Stony Brook Medicine

The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International Inc., a U.S. based healthcare company, revealed it to be promising and well tolerated, according to a research paper published online in The Lancet Infectious Diseases. The vaccine was shown to produce substantial antibodies against all targeted species of Borrelia, the causative agent of Lyme disease in Europe and the United States. Baxter International conducted the clinical trial of the vaccine.

3-May-2013 10:00 AM EDT
Preclinical Study Shows Heroin Vaccine Blocks Relapse
Scripps Research Institute

Scientists at The Scripps Research Institute (TSRI) have reported successful preclinical tests of a new vaccine against heroin. The vaccine targets heroin and its psychoactive breakdown products in the bloodstream, preventing them from reaching the brain.

   
3-May-2013 1:00 PM EDT
Competing Antibodies May Have Limited the Protection Achieved in HIV Vaccine Trial in Thailand
Duke Health

Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.

Released: 2-May-2013 10:00 AM EDT
Focus on STD, Not Cancer Prevention, to Promote HPV Vaccine Use
Ohio State University

The HPV vaccine can prevent both cervical cancer and a nasty sexually transmitted disease in women. But emphasizing the STD prevention will persuade more young women to get the vaccine, a new study suggests.

29-Apr-2013 12:00 PM EDT
Mayo Clinic Discovers Why Some Don’t Respond to Rubella Vaccine
Mayo Clinic

Using advanced genetic sequencing technology and analysis, Mayo Clinic vaccine researchers have identified 27 genes that respond in very different ways to the standard rubella vaccine, making the vaccine less effective for a portion of the population.

25-Apr-2013 5:00 PM EDT
Study Compares Effectiveness of 2 vs. 3 Doses of HPV Vaccine For Girls and Young Women
JAMA - Journal of the American Medical Association

With the number of doses and cost of human papillomavirus (HPV) vaccines a barrier to global implementation, researchers have found that girls who received two doses of HPV vaccine had immune responses to HPV-16 and HPV-18 infection that were noninferior to (not worse than) the responses for young women who received three doses, according to a study in the May 1 issue of JAMA, a theme issue on child health.

16-Apr-2013 4:30 PM EDT
Researchers Use Web 2.0 Apps to Share Vaccine Study
Benaroya Research Institute at Virginia Mason

Research utilizing a systems approach demonstrates that different vaccines lead to immunity via distinct immune response pathways. Published findings include interactive figures linked to the underlying data allowing readers seamless access to investigate new hypotheses.

16-Apr-2013 2:00 PM EDT
Researchers Develop Web 2.0 Apps to Share Vaccine Study
Baylor Scott and White Health

Research utilizing a systems approach demonstrates that different vaccines lead to immunity via distinct immune response pathways. Published findings include interactive figures linked to the underlying data allowing readers seamless access to investigate new hypotheses.

15-Apr-2013 5:00 PM EDT
Why Does Smallpox Vaccine Shield Some, Not Others? It’s in the Genes
Mayo Clinic

How well people are protected by the smallpox vaccine depends on more than the quality of the vaccination: individual genes can alter their response, Mayo Clinic research shows.

Released: 15-Apr-2013 6:00 AM EDT
La Jolla Institute’s Surprising Finding Could Alter the Face of Dengue Vaccine Development
La Jolla Institute for Immunology

As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine.

29-Mar-2013 8:00 AM EDT
Investigational Vaccine Not Effective in Reducing Post-Operative Staph Infections
JAMA - Journal of the American Medical Association

Use of a vaccine to prevent Staphylococcus aureus infections among patients undergoing cardiothoracic surgery did not reduce the rate of serious postoperative S aureus infections compared with placebo and was associated with increased mortality among patients who developed S aureus infections, according to a study in the April 3 issue of JAMA.

Released: 1-Apr-2013 5:00 PM EDT
New Promise for an HIV Vaccine as Researchers Overcome Crucial Obstacle
Center for Infectious Disease Research, formerly Seattle Biomedical Research Institute (Seattle BioMed)

For the first time, researchers were able to stimulate immune cells to produce broadly neutralizing antibodies: a critical step that has eluded researchers for decades but that provides promise for a successful HIV vaccine.

Released: 28-Mar-2013 3:40 PM EDT
New Vaccine-Design Approach Targets Viruses Such as HIV
Scripps Research Institute

A team led by scientists from The Scripps Research Institute and the International AIDS Vaccine Initiative has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

   
Released: 27-Mar-2013 11:00 AM EDT
Researchers Analyze HPV Vaccination Disparities among Girls from Low-Income Families
Moffitt Cancer Center

Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus (HPV) vaccination among girls, ages 9 to 17, from low-income families. They found that physician vaccination strategies and the type of practice play a role in whether or not girls were vaccinated.

Released: 25-Mar-2013 11:00 AM EDT
Researchers Developing Antiviral Drug to Combat Contagious Norovirus
Kansas State University

A Kansas State University-led team is researching ways to stop the spread of norovirus, a contagious stomach illness that infects one in 15 Americans each year.

Released: 22-Mar-2013 2:00 PM EDT
Research Reveals Protective Properties of Influenza Vaccines
Nationwide Children's Hospital

Collaborating scientists from Nationwide Children’s Hospital, Baylor Institute for Immunology Research, and Mount Sinai School of Medicine have identified an important mechanism for stimulating protective immune responses following seasonal influenza vaccinations. The study was published in Science Translational Medicine, a journal of the American Association for the Advancement of Science (AAAS).

15-Mar-2013 12:05 PM EDT
More Parents Say They Won’t Vaccinate Daughters Against HPV
Mayo Clinic

Parents increasingly concerned about potential side effects, study shows

13-Mar-2013 3:30 PM EDT
Two-Pronged Immune Cell Approach Could Lead to a Universal Shot Against the Flu
Perelman School of Medicine at the University of Pennsylvania

Influenza virus-specific CD8+ T cells or virus-specific non-neutralizing antibodies are each relatively ineffective at conferring protective immunity alone. But, when combined, the virus-specific CD8 T cells and non-neutralizing antibodies cooperatively elicit robust protective immunity.

Released: 13-Mar-2013 9:00 AM EDT
Chicken Pox Vaccine Saving Children's Lives
University of Adelaide

The widespread introduction of a chicken pox vaccine in Australia in 2006 has prevented thousands of children from being hospitalized with severe chicken pox and saved lives, according to new research.

Released: 12-Mar-2013 8:35 AM EDT
Needle-Free Vaccine for Ear Infections Could Also Help Reduce Use of Antibiotics
Ohio State University Center for Clinical and Translational Science

Researchers have found a new vaccine that both prevents and treats ear infections - minus the needle jab. The vaccine - which targets the bacteria responsible for half of all ear infections - would be delivered through the skin via a small, dime-sized patch. The non-needle vaccine appears to pack a one-two punch against nontypeable Haemophilus influenzae (NTHI), attacking key parts of the bacteria’s defenses and kick-starting the body’s own immune system to help clear out the infection.

1-Mar-2013 11:00 AM EST
Cancer Vaccines Self-Sabotage, Channel Immune Attack to Injection Site
University of Texas MD Anderson Cancer Center

Cancer vaccines that attempt to stimulate an immune system assault fail because the killer T cells aimed at tumors instead find the vaccination site a more inviting target, scientists at The University of Texas MD Anderson Cancer Center report in Nature Medicine.

Released: 25-Feb-2013 3:45 PM EST
New Staph Vaccine, Diagnostics Best New Invention at UMd/JHU Tech Alliance
University of Maryland, Baltimore

School of Dentistry researcher revealed details of protective vaccine against MRSA other Staphs to audience of venture capitalists and biotech entrepreneurs.

Released: 21-Feb-2013 2:00 PM EST
Study Reveals New Clues to Epstein-Barr Virus
Beth Israel Lahey Health

BIDMC researchers identify a second B-cell attachment receptor for this widespread virus.

15-Feb-2013 9:00 AM EST
Cancer Research, Environment and Climate Change, Nutrition, and Mental Health - Upcoming Newswise Theme Wires
Newswise

Newswise invites press release submissions from new and current members for inclusion in our Theme Wires on a variety of topics, including; Cancer Research, Environment and Climate Change, Nutrition, and Mental Health. Each wire is also open for sponsorships to promote your organization’s campaign, product, service, or news.

       
Released: 6-Feb-2013 10:00 AM EST
Shingles Vaccination Is a Must, Says UB Microbiologist, Who Knows From Experience
University at Buffalo

Terry D. Connell, PhD, knows a lot about the immune system: he’s a University at Buffalo professor in the Department of Microbiology and Immunology in the School of Medicine and Biomedical Sciences who conducts research on new vaccines for diseases, such as tuberculosis. But his academic credentials are only part of the reason that he strongly believes that everyone over the age of 60 should get a shingles vaccination.

Released: 4-Feb-2013 3:25 PM EST
Two-Step Immunotherapy Attacks Advanced Ovarian Cancer
Perelman School of Medicine at the University of Pennsylvania

Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment — a dendritic cell vaccine using patients’ own tumor followed by adoptive T cell therapy — triggers anti-tumor immune responses in these type of patients. Four of the six patients treated in the trial responded to the therapy, the investigators report this month in OncoImmunology.

Released: 31-Jan-2013 11:30 AM EST
A Novel Pathway for a Mucosal TB Vaccine
University at Buffalo

A new pathway for improving vaccines against tuberculosis has been discovered by microbiologists at the University at Buffalo in collaboration with researchers at other universities, according to a paper in the journal Mucosal Immunology, published by the Nature group.

Released: 31-Jan-2013 10:00 AM EST
Fact or Fiction: Busting Myths About Colds and the Flu
Loyola Medicine

Loyola University Health System pediatric infectious disease expert separates fact from fiction.

Released: 22-Jan-2013 9:45 AM EST
Children with Egg Allergies Can Safely Receive Flu Vaccine
Michigan Medicine - University of Michigan

Egg allergic children did not have adverse reactions to single dose of influenza vaccine in multi-center study.

Released: 21-Jan-2013 8:00 AM EST
Time to Mandate Flu Vaccines for Healthcare Workers, Says Health Law Expert
Washington University in St. Louis

The widespread flu reports are a harsh reminder of the importance of influenza vaccines. This is particularly true for healthcare workers, says Elizabeth Sepper, JD, health law expert and professor of law at Washington University in St. Louis. “One-third of healthcare providers fail to protect themselves, their patients, and the public from influenza.” Sepper says that it is time for a national flu vaccine mandate for healthcare workers.

Released: 18-Jan-2013 11:45 AM EST
Three Questions About HPV Vaccination
National Cancer Institute (NCI) at NIH

In 2009, more than 30,000 people in the U.S. learned they had cancer linked to the human papillomavirus, or HPV. This virus is best known for causing cervical cancer, but it’s also the culprit behind many cancers of the mouth, throat, anus, and genitals. Unlike many forms of cancer, for which we lack the knowledge and tools to prevent, scientists have figured out how to dodge HPV-triggered cancers — by HPV vaccination. Vaccination against HPV thwarts the viruses’ spread, wrecking its ability to jump between people. Wiping out HPV could mean shutting down a big source of cancer cases — more than 3 percent of all diagnoses nationwide.

16-Jan-2013 8:00 AM EST
H1N1 Flu Shots Are Safe for Pregnant Women: NIH Researcher Assists in Study of Norwegian Women
National Institute of Environmental Health Sciences (NIEHS)

Norwegian pregnant women who received a vaccine against the 2009 H1N1 influenza virus showed no increased risk of pregnancy loss, while pregnant women who experienced influenza during pregnancy had an increased risk of miscarriages and still births, a study has found. The study suggests that influenza infection may increase the risk of fetal loss.

Released: 16-Jan-2013 11:00 AM EST
Institute of Medicine Report Details Strategy for Monitoring Safety of Childhood Immunization Schedule
University of Michigan

A review of the available evidence underscores the safety of the federal childhood immunization schedule, according to a report released today by the Institute of Medicine. University of Michigan population ecologist Pejman Rohani served on the 13-person committee that wrote the report.

Released: 11-Jan-2013 9:00 AM EST
Children Once in Danger of Flu Shot can get Vaccinated
American College of Allergy, Asthma and Immunology (ACAAI)

As many as two percent of children may not receive the flu vaccination due to an egg allergy. But according to the American College of Allergy, Asthma and Immunology (ACAAI) and a recent study in Annals of Allergy, Asthma &Immunology, administration is safe even in children with a history of a severe allergic reaction to eggs.

11-Jan-2013 7:00 AM EST
Game-Based Economics Research Explains Why We Roll the Dice on Flu Shots
Wake Forest University

Using an online computer game that simulates the spread of an infectious disease among its players, researchers at Wake Forest University learned more about what motivates people to protect themselves from infection – from the flu to whooping cough.

Released: 10-Jan-2013 5:30 PM EST
Flu Vaccine Rates in Children Remain Lower Than Expected, Despite Recommendations
Atrium Health Wake Forest Baptist

This year’s flu season is in full swing with 41 states now reporting widespread illness. Unfortunately, not enough children are getting the flu shot even though health officials recommend that all children 6 months and older get the vaccine. According to a new study by researchers at Wake Forest Baptist Medical Center, less than 45 percent of children were vaccinated against the flu during a five-year study period.

Released: 8-Jan-2013 12:30 PM EST
In January – Cervical Cancer Awareness Month – Vaccinate Your Child Against HPV
Seattle Cancer Care Alliance

Preventable strands of the human papilloma virus (HPV) are linked to 70 percent of all cervical cancer cases. Adolescent vaccination dramatically reduces your daughter’s risk of transmitting or contracting cancer-causing HPV in adulthood.



close
2.59734